Opioid withdrawal and naltrexone induction in 48-72 hours with minimal drop-out, using a modification of the naltrexone-clonidine technique

scientific article

Opioid withdrawal and naltrexone induction in 48-72 hours with minimal drop-out, using a modification of the naltrexone-clonidine technique is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1192/BJP.153.3.340
P698PubMed publication ID3250670
P5875ResearchGate publication ID19904978

P2093author name stringBrewer C
Bailey C
Rezae H
P407language of work or nameEnglishQ1860
P921main subjectnaltrexoneQ409587
opioidQ427523
P304page(s)340-343
P577publication date1988-09-01
P1433published inBritish Journal of PsychiatryQ4035428
P1476titleOpioid withdrawal and naltrexone induction in 48-72 hours with minimal drop-out, using a modification of the naltrexone-clonidine technique
P478volume153

Reverse relations

cites work (P2860)
Q4398987024-Hour opiate detoxification and antagonist induction at home--the 'Asturian method': a report on 1368 procedures
Q52317035Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies.
Q51117857Definitive treatment in the psychiatric emergency service.
Q47569719Effect of adenosine analogues on the expression of opiate withdrawal in rats
Q45170236Effect of alpha 2-adrenoceptor agonists on the expression of morphine-withdrawal in rats
Q44786991Experience with clonidine-naltrexone for rapid opiate detoxification
Q39456901Formulation and stability of naltrexone oral liquid for rapid withdrawal from methadone
Q52266545Naloxone and opiate addiction.
Q59768935Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification
Q28374621Naltrexone shortened opioid detoxification with buprenorphine
Q58251481On the Specific Effectiveness, and Under-Valuing, of Pharmacological Treatments for Addiction: A Comparison of Methadone, Naltrexone and Disulfiram with Psychosocial Interventions
Q51470845Opiate detoxification under anesthesia: no apparent benefit but suppression of thyroid hormones and risk of pulmonary and renal failure.
Q24240041Opioid antagonists with minimal sedation for opioid withdrawal
Q24244653Opioid antagonists with minimal sedation for opioid withdrawal
Q56289303Opioid antagonists with minimal sedation for opioid withdrawal
Q35090939Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice
Q40694687Rapid heroin detoxification using a single high dose of buprenorphine
Q52278123Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance.
Q34371727Rapid opiate detoxification and antagonist induction under general anaesthesia or intravenous sedation is humane, sometimes essential and should always be an option. Three illustrative case reports involving diabetes and epilepsy and a review of the
Q41359380Rapid opioid detoxification using opioid antagonists: history, theory and the state of the art.
Q41167854Similar efficacy of abrupt and gradual opiate detoxification
Q52279689The impact of naloxone/lofexidine combination treatment on the opiate withdrawal syndrome.
Q51488279Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results.
Q48742830Ultra-rapid, antagonist-precipitated opiate detoxification under general anaesthesia or sedation

Search more.